ADMA BIOLOGICS, INC.

ADMA Biologics, Inc.

Biotechnology • Healthcare • Ramsey, NJ, United States • ADMA (NGM)

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.

201 478 5552 465 State Route 17, Ramsey, NJ 07446, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Why Adma Biologics (ADMA) Outpaced the Stock Market Today - Yahoo Finance
Yahoo Finance • Jan 6
A Look At ADMA Biologics (ADMA) Valuation As J.P. Morgan Healthcare Conference Presentation Nears - simplywall.st
simplywall.st • Jan 5
ADMA Biologics (ADMA): Firm Updates 2025 Revenue Guidance - Yahoo Finance
Yahoo Finance • Dec 21
The Play On ADMA Biologics: A Discounted Stock With Good Prospects (NASDAQ:ADMA) - Seeking Alpha
Seeking Alpha • Dec 12
Stocks With Rising Relative Strength: ADMA Biologics - Investor's Business Daily
Investor's Business Daily • Dec 22

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has ADMA BIOLOGICS, INC. had layoffs?
No layoff events have been recorded for ADMA BIOLOGICS, INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does ADMA BIOLOGICS, INC. have?
ADMA BIOLOGICS, INC. has approximately 677 employees.
What industry is ADMA BIOLOGICS, INC. in?
ADMA BIOLOGICS, INC. operates in the Biotechnology industry, within the Healthcare sector.
Is ADMA BIOLOGICS, INC. a publicly traded company?
Yes, ADMA BIOLOGICS, INC. is publicly traded under the ticker symbol ADMA on the NGM. The company has a market capitalization of approximately $4.60 billion.
Where is ADMA BIOLOGICS, INC. headquartered?
ADMA BIOLOGICS, INC. is headquartered in Ramsey, NJ, United States at 465 State Route 17, Ramsey, NJ 07446, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.